2024
In Support of Overdose Prevention Centers: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education and Research in Substance Use and Addiction)
Dunham K, Hill K, Kazal H, Butner J, Hull I, Sue K, Li L, Doneski K, Dinges B, Rife-Pennington T, Kung S, Thakarar K. In Support of Overdose Prevention Centers: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education and Research in Substance Use and Addiction). Substance Abuse 2024, 45: 328-336. PMID: 38747578, DOI: 10.1177/29767342241252590.Peer-Reviewed Original ResearchPrevention CenterRates of fatal overdoseSubstance Use and AddictionDrop-in serviceEvidence-based strategiesHarm reduction strategiesMultidisciplinary Education and ResearchUnited StatesLifesaving servicesMedical careAdvocacy effortsIncrease accessPosition statementSocial servicesFatal overdoseEducation and ResearchDrug supplyTrained personnelPWUDPolicy changesFederal levelReduction strategiesInternational dataSterile suppliesServices
2023
In Support of Community Drug Checking Programs: Position Statement of AMERSA, Inc. (Association for Multidisciplinary Education and Research in Substance use and Addiction)
Hill K, Dunham K, Brokos Z, Butner J, Hull I, Sue K, Li L, Thakarar K. In Support of Community Drug Checking Programs: Position Statement of AMERSA, Inc. (Association for Multidisciplinary Education and Research in Substance use and Addiction). Substance Abuse 2023, 45: 4-9. PMID: 38258861, DOI: 10.1177/29767342231212787.Peer-Reviewed Original ResearchHarm reduction strategiesPosition statementSerious adverse eventsImportant harm reduction strategyPublic health practitionersAdverse eventsUnregulated drug supplyFatal overdosesHealthcare providersComposition of drugsHealth consequencesHealth practitionersDrugsDrug supplyInsufficient dataDrug checkingUnited States
2021
A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic
Farhoudian A, Radfar SR, Ardabili H, Rafei P, Ebrahimi M, Zonoozi A, De Jong CAJ, Vahidi M, Yunesian M, Kouimtsidis C, Arunogiri S, Hansen H, Brady KT, Consortium I, Abagiu A, Abouna F, Ahmed M, Al-ansari B, Abu Al-khair F, Almaqbali M, Ambekar A, Arya S, Asebikan V, Ayasreh M, Basu D, Benmebarek Z, Bhad R, Blaise M, Bonnet N, Brasch J, Broers B, Busse A, Butner J, Camilleri M, Campello G, Carra G, Celic I, Chalabianloo F, Chaturvedi A, de JesĂşs Eduardo Noyola Cherpitel J, Clark K, Cyders M, de Bernardis E, Deilamizade A, Derry J, Dhagudu N, Dolezalova P, Dom G, Dunlop A, Elhabiby M, Elkholy H, Essien N, Farah G, Ferri M, Floros G, Friedman C, Fuderanan C, Gerra G, Ghosh A, Gogia M, Grammatikopoulos I, Grandinetti P, Guirguis A, Gutnisky D, Haber P, Hassani-Abharian P, Hooshyari Z, Ibrahim I, Ieong H, Indradewi R, Iskandar S, Isra T, Jain S, James S, Javadi S, Joe K, Jokubonis D, Jovanova A, Kamal R, Kantchelov A, Kathiresan P, Katzman G, Kawale P, Kern A, Kessler F, Kim S, Kimball A, Kljucevic Z, Kurniasanti K, Lev R, Lee H, Lengvenyte A, Lev-ran S, Mabelya G, Mahi M, Maphisa J, Maremmani I, Masferrer L, Massah O, McCambridge O, McGovern G, Min A, Moghanibashi-Mansourieh A, Mora-Rios J, Mudalige I, Mukherjee D, Munira P, Myers B, N. J, Narasimha V, Ndionuka N, Nejatisafa A, Niaz K, Nizami A, Nuijens J, Orsolini L, Oum V, Oyemade A, Palavra I, Pant S, Paredes J, Peyron E, QuirĂłs R, Qurishi R, Rafiq N, Rao R, Ratta-apha W, Raymond K, Reimer J, Renaldo E, Rezapour T, Robertson J, Roncero C, Roub F, Rubenstein E, Rupp C, Saenz E, Salehi M, Samartzis L, Sarubbo L, Segrec N, Shah B, Shen H, Shirasaka T, Shoptaw S, Sintango F, Sosa V, Subata E, Sztycberg N, Taghizadeh F, Teck J, Tjagvad C, Torrens M, Twala J, Vadivel R, Volpicelli J, Weijs J, Wintoniw S, Wittayanookulluk A, Wojnar M, Yasir S, Yitayih Y, Zhao M, Potenza M, Baldacchino A, Ekhtiari H. A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic. Frontiers In Psychiatry 2021, 12: 646206. PMID: 34421664, PMCID: PMC8377291, DOI: 10.3389/fpsyt.2021.646206.Peer-Reviewed Original ResearchSubstance use disordersRelated complicationsCOVID-19 pandemicComplications of alcoholSubstance use patternsCross-sectional surveyCurrent pandemicUse of amphetaminesHypnotic usePrescription opioidsEpidemiologic studiesUse disordersMedicine NetworkComplicationsVulnerable populationsMedicine professionalsDrug supplyDrugsIllicit drugsPossible downstream effectsCOVID-19International SocietyDownstream effectsUse patternsPandemic
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply